Streamlining immune cell therapy manufacturing workflows with single-use cytokines
Upcoming webinar

Streamlining immune cell therapy manufacturing workflows with single-use cytokines

Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Streamlining immune cell therapy manufacturing workflows with single-use cytokines

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.

Transitioning an immune cell therapy program from research to the clinic requires consistent and scalable cell manufacturing processes. Streamlining cell manufacturing workflows by eliminating manual touchpoints reduces variability and supports process scaling.

Cytokine delivery is one such opportunity for workflow improvement. Traditionally, cytokines are supplied in large volumes, which require manual aliquoting prior to storage and use. This step introduces a risk of error, threatens consistency, and impedes scale-up. Bio-Techne has addressed this challenge with new single-use vials with process-optimized concentrations of our GMP cytokines for streamlined immune cell manufacturing.

In this webinar, we examine the workflow difficulties posed by traditional cytokine delivery and the benefits of transitioning to a single-use cytokine method. We will also explore the need for scalable, aseptic closed-systems for immune cell manufacturing and Bio-Techne’s plans to solve that need with complete workflow solutions.

In this webinar, you will learn more about:

  • How consistent and scalable manufacturing workflows impact immune cell therapy development
  • New single-use cytokines with process-optimized concentrations
  • Comparing workflows using traditional and single-use cytokine methods
Gabriella Perell
Gabriella Perell
Global Strategic Senior Product Manager at Bio-Techne

Gabriella Perell is a Global Strategic Senior Product Manager for the proteins division, and previously managed the cell and gene therapy product lines focused on immune and stem cell therapy tools at Bio-Techne. Prior to this, Gabriella worked in process development at Amgen. Gabriella obtained her doctorate from the University of Minnesota investigating protein-protein interactions, and holds a bachelors in Chemistry from the University of St. Thomas.